1. Home
  2. PROV vs FATE Comparison

PROV vs FATE Comparison

Compare PROV & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

SELL

Current Price

$18.15

Market Cap

107.4M

Sector

Finance

ML Signal

SELL

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
FATE
Founded
1956
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
125.6M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
PROV
FATE
Price
$18.15
$1.79
Analyst Decision
Hold
Buy
Analyst Count
2
11
Target Price
★ $18.50
$5.74
AVG Volume (30 Days)
12.4K
★ 1.6M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
★ 3.09%
N/A
EPS Growth
10.75
★ 29.88
EPS
★ 1.03
N/A
Revenue
N/A
★ $6,646,000.00
Revenue This Year
$3.36
N/A
Revenue Next Year
$0.24
N/A
P/E Ratio
$17.58
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$14.95
$0.95
52 Week High
$18.99
$3.23

Technical Indicators

Market Signals
Indicator
PROV
FATE
Relative Strength Index (RSI) 40.94 25.20
Support Level $18.05 $1.59
Resistance Level $18.91 $2.60
Average True Range (ATR) 0.25 0.14
MACD -0.04 -0.05
Stochastic Oscillator 3.90 1.29

Price Performance

Historical Comparison
PROV
FATE

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: